Zimbabwe has declined a major US health deal worth 367 million US dollars (272 million pounds) over five years over Washington's request for sensitive information.
This rejection became public following a official document from December was disclosed, which showed Head of State Emmerson Mnangagwa deemed the arrangement was "lopsided".
A government representative later clarified that the United States was demanding access to genetic material for scientific study and commercial purposes while refused to share the benefits from any future treatments.
"We are forced to start the difficult and regrettable task of winding down our health assistance in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy indicated the US had provided more than $1.9bn in health funding to Zimbabwe over the last twenty years.
A medical body in Zimbabwe has appealed for further talks to find a deal agreeable to all parties so the nation's vital HIV treatment initiative can be sustained.
Wider Background
This rejection comes after a comparable case in neighbouring Kenya, where a court suspended a related health funding agreement after legal challenges were raised about the safety of Kenyans' health data.
Since resuming the presidency last year, US President Donald Trump has slashed overseas assistance and shut down the key foreign aid agency.
USAID had overseen aid for the American government, but Trump claimed its spending was "inefficient" and his administration was seeking direct bilateral deals to boost transparency and responsibility.
As per reports, 16 African countries have so far agreed to similar health pacts, representing over $18.3bn of fresh investment.
Details of the Rejected Agreement
This assistance for Zimbabwe would have funded "combating HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.
"It is our view this collaboration could have provided immense benefits for the people of Zimbabwe, particularly the 1.2 million presently on HIV treatment through American-funded programmes," Tremont added.
However, government spokesperson Nick Mangwana argued the proposed deal was "unequal".
"The proposal required Zimbabwe to surrender its genetic material and health information for a long time, with no corresponding assurance of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that might result from that provided information," his statement read.
"Effectively, our country would provide the basic resources for medical research without any assurance that the end products would be available to our population should a future disease outbreak arise."
National Interest and Global Health
He also pointed out that the American exit from the World Health Organization (WHO) and its pursuit of bilateral health agreements were disrupting frameworks already established via the international organization.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing framework designed to deal with potential global health emergencies.
"This framework is intended to guarantee that when a nation contributes its information, the resulting advantages – including medicines and cures – are distributed fairly, not commercialised solely by those with the funds to develop them."
The government's concerns over the US deal "must not be interpreted as hostility towards the US," he added.
"We are open to continued discussions with our US partners on how future co-operation might be arranged in a manner that respects the sovereignty and dignity of both nations."
Medical Community Response
Medical experts stated it understood the official position, but urged that talks need to persist given that a large portion of the country's Aids initiatives depended on international support.
"Where specific concerns arise, including those involving data governance or agreement terms, these can frequently be resolved through detailed discussion and mutually agreed protections," the group commented.
The situation emphasises the complex debate between receiving vital international aid and protecting a country's data in an increasingly interconnected world.